These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 19733017)
1. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Rades D; Heisterkamp C; Huttenlocher S; Bohlen G; Dunst J; Haatanen T; Schild SE Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):537-41. PubMed ID: 19733017 [TBL] [Abstract][Full Text] [Related]
2. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose? Rades D; Heisterkamp C; Schild SE Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627 [TBL] [Abstract][Full Text] [Related]
3. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Rades D; Pluemer A; Veninga T; Dunst J; Schild SE Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659 [TBL] [Abstract][Full Text] [Related]
4. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder. Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794 [TBL] [Abstract][Full Text] [Related]
5. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520 [TBL] [Abstract][Full Text] [Related]
7. Reduction of overall treatment time in patients irradiated for more than three brain metastases. Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033 [TBL] [Abstract][Full Text] [Related]
8. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853 [TBL] [Abstract][Full Text] [Related]
11. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients. Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949 [TBL] [Abstract][Full Text] [Related]
12. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523 [TBL] [Abstract][Full Text] [Related]
13. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases. Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817 [TBL] [Abstract][Full Text] [Related]
14. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC). Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229 [TBL] [Abstract][Full Text] [Related]
15. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126 [TBL] [Abstract][Full Text] [Related]
16. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294 [TBL] [Abstract][Full Text] [Related]
17. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases. Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485 [TBL] [Abstract][Full Text] [Related]
18. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155 [TBL] [Abstract][Full Text] [Related]
19. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Nieder C; Andratschke N; Grosu AL; Molls M Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980 [TBL] [Abstract][Full Text] [Related]
20. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Rades D; Panzner A; Dziggel L; Haatanen T; Lohynska R; Schild SE Cancer; 2012 Aug; 118(15):3852-9. PubMed ID: 22170514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]